n-formylmethionyl-leucyl-phenylalanyl-lysine has been researched along with Myelodysplastic Syndromes in 1 studies
*Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drayer, AL; Fuhler, GM; Hooijenga, F; Vellenga, E | 1 |
1 other study(ies) available for n-formylmethionyl-leucyl-phenylalanyl-lysine and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Reduced expression of flavocytochrome b558, a component of the NADPH oxidase complex, in neutrophils from patients with myelodysplasia.
Topics: Adult; Aged; Aged, 80 and over; Cytochrome b Group; Female; Gene Expression Regulation, Enzymologic; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Male; Middle Aged; Myelodysplastic Syndromes; N-Formylmethionine Leucyl-Phenylalanine; NADPH Oxidases; Neutrophil Activation; Neutrophils; Reactive Oxygen Species | 2003 |